Northwest Biotherapeutics (NWBO) EPS (Basic) (2010 - 2026)
Northwest Biotherapeutics' (NWBO) quarterly EPS (Basic) came in at -$0.0 in Q1 2026, up 99.99% year-on-year from -$0.0 in Q1 2025, and down 349.8% quarter-over-quarter from $0.0 in Q4 2025.
Northwest Biotherapeutics (NWBO) EPS (Basic) (2010 - 2026) Analysis & Trends
Northwest Biotherapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 99.99% year-over-year to -$0.0 in Q1 2026; TTM through Mar 2026 was -$0.03, a 99.95% increase from a year earlier, with the FY2025 full-year figure at -$0.04, up 99.94% from the prior year.
- EPS (Basic) retreated to -$0.0 in Q1 2026 per NWBO's latest filing, from $0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.0 in Q4 2025 and bottomed at -$31.56 in Q3 2022.
- The 5-year median for EPS (Basic) is -$15.08 (2024), against an average of -$16.16.
- Across the five-year window, EPS (Basic) plunged 726.85% in 2022 and soared 100.0% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$27.86 in 2022, then soared by 54.07% to -$12.79 in 2023, then tumbled by 79.31% to -$22.94 in 2024, then soared by 100.0% to $0.0 in 2025, then tumbled by 349.8% to -$0.0 in 2026.
- Per Business Quant, the three latest NWBO EPS (Basic) figures stand at -$0.0 (Q1 2026), $0.0 (Q4 2025), and -$18.22 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -18.22 |
| Jun 30, 2025 | -11.08 |
| Mar 31, 2025 | -14.42 |
| Dec 31, 2024 | -22.94 |
| Sep 30, 2024 | -15.50 |
| Jun 30, 2024 | -15.08 |
| Mar 31, 2024 | -15.89 |
| Dec 31, 2023 | -12.79 |
| Sep 30, 2023 | -21.19 |
| Jun 30, 2023 | -13.50 |
| Mar 31, 2023 | -10.28 |
| Dec 31, 2022 | -27.86 |
| Sep 30, 2022 | -31.56 |
| Jun 30, 2022 | -29.55 |
| Mar 31, 2022 | -14.82 |
| Dec 31, 2021 | 204.73 |
| Sep 30, 2021 | 5.03 |
| Jun 30, 2021 | 5.18 |